XML 66 R56.htm IDEA: XBRL DOCUMENT v3.22.2.2
Contingent Consideration - Reconciliation of the Beginning and Ending Balances Related to the Contingent Consideration (Details) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2022
Dec. 31, 2021
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]    
Balance at December 31, 2021 $ 80,477  
Milestone payments (25,000)  
Change in fair value recognized in earnings 1,894  
Balance at September 30, 2022 (unaudited) 57,371  
Contingent consideration, current portion 47,590 $ 44,840
Contingent consideration, long-term 9,781 35,637
Contingent consideration 57,371 $ 80,477
Regulatory and developmental contingent consideration liabilities    
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]    
Contingent consideration 47,590  
Sales-based contingent consideration liabilities    
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]    
Contingent consideration 9,781  
USWM Enterprises    
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]    
Balance at December 31, 2021 70,170  
Milestone payments (25,000)  
Change in fair value recognized in earnings 2,420  
Balance at September 30, 2022 (unaudited) 47,590  
Contingent consideration 47,590  
USWM Enterprises | Regulatory and developmental contingent consideration liabilities    
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]    
Contingent consideration 47,590  
USWM Enterprises | Sales-based contingent consideration liabilities    
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]    
Contingent consideration 0  
Adamas Acquisition    
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]    
Balance at December 31, 2021 10,307  
Milestone payments 0  
Change in fair value recognized in earnings (526)  
Balance at September 30, 2022 (unaudited) 9,781  
Contingent consideration 9,781  
Adamas Acquisition | Regulatory and developmental contingent consideration liabilities    
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]    
Contingent consideration 0  
Adamas Acquisition | Sales-based contingent consideration liabilities    
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]    
Contingent consideration $ 9,781